Skip to main content

Market Overview

12 Health Care Stocks Moving In Monday's Intraday Session

Share:

 

Gainers

  • Celldex Therapeutics (NASDAQ:CLDX) stock increased by 21.35% to $39.33 during Monday's regular session. Celldex Therapeutics's stock is trading at a volume of 4.9 million shares as of 12:30 EST. This is 918.65% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.5 billion.
  • SCWorx (NASDAQ:WORX) stock increased by 18.56% to $1.98. Trading volume for SCWorx's stock is 6.3 million as of 12:30 EST. This is 1646.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $19.8 million.
  • Biophytis (NASDAQ:BPTS) shares moved upwards by 17.2% to $10.6. As of 12:30 EST, this security is trading at a volume of 2.5K shares, making up 98.86% of its average full-day volume over the last 100 days. The company's market cap stands at $120.5 million.
  • Ayala Pharmaceuticals (NASDAQ:AYLA) stock increased by 13.4% to $9.33. Trading volume for Ayala Pharmaceuticals's stock is 20.1K as of 12:30 EST. This is 154.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $123.5 million.
  • Alphatec Holdings (NASDAQ:ATEC) shares rose 13.21% to $16.02. Trading volume for this security as of 12:30 EST is 1.0 million, which is 220.02% of its average full-day volume over the last 100 days. The company's market cap stands at $1.5 billion.
  • Oramed Pharmaceuticals (NASDAQ:ORMP) shares increased by 11.95% to $13.77. Trading volume for this security as of 12:30 EST is 1.1 million, which is 231.25% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $427.3 million.

 

 

Losers

 

  • TransMedics Group (NASDAQ:TMDX) stock fell 10.17% to $31.0 during Monday's regular session. The current volume of 329.4K shares is 81.19% of TransMedics Group's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $856.3 million.
  • GBS (NASDAQ:GBS) stock fell 9.69% to $3.45. Trading volume for GBS's stock is 150.2K as of 12:30 EST. This is 21.04% of its average full-day volume over the last 100 days. The company's market cap stands at $42.7 million.
  • ASLAN Pharmaceuticals (NASDAQ:ASLN) shares fell 8.21% to $3.13. Trading volume for this security as of 12:30 EST is 1.8 million, which is 225.01% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $217.6 million.
  • Evoke Pharma (NASDAQ:EVOK) stock declined by 8.01% to $1.15. The current volume of 189.8K shares is 61.4% of Evoke Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $37.2 million.
  • Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 7.89% to $19.63. As of 12:30 EST, Taysha Gene Therapies's stock is trading at a volume of 36.6K, which is 19.42% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $744.3 million.
  • Sigilon Therapeutics (NASDAQ:SGTX) shares declined by 7.25% to $6.4. As of 12:30 EST, Sigilon Therapeutics's stock is trading at a volume of 414.2K, which is 217.69% of its average full-day volume over the last 100 days. The company's market cap stands at $201.7 million.

 

 

 

Related Articles (ATEC + ASLN)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com